TuisCAMX โข STO
add
Camurus AB
Vorige sluiting
krย 515,00
Dagwisseling
krย 516,50 - krย 535,00
Jaarwisseling
krย 430,80 - krย 754,50
Markkapitalisasie
30,89ย mjd SEK
Gemiddelde volume
111,53ย k
P/V-verhouding
-
Dividend-opbrengs
-
Primรชre beurs
STO
Marknuus
.INX
0,70%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (SEK) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 464,46ย m | -16,03% |
Bedryfskoste | 315,31ย m | -12,24% |
Netto inkomste | 100,88ย m | -31,36% |
Netto winsgrens | 21,72 | -18,25% |
Wins per aandeel | 1,67 | -31,84% |
EBITDA | 119,44ย m | -27,19% |
Effektiewe belastingkoers | 20,47% | โ |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (SEK) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,73ย mjd | 30,61% |
Totale bates | 4,74ย mjd | 26,16% |
Totale aanspreeklikheid | 504,56ย m | 7,97% |
Totale ekwiteit | 4,24ย mjd | โ |
Uitstaande aandele | 59,64ย m | โ |
Prys om te bespreek | 7,25 | โ |
Opbrengs op bates | 6,02% | โ |
Opbrengs op kapitaal | 6,58% | โ |
Kontantvloei
Netto kontantverandering
| (SEK) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 100,88ย m | -31,36% |
Kontant van bedrywe | 255,43ย m | 147,39% |
Kontant van beleggings | -45,79ย m | -130,25% |
Kontant van finansiering | 3,09ย m | -79,97% |
Netto kontantverandering | 211,26ย m | 108,27% |
Beskikbare kontantvloei | 104,90ย m | 273,91% |
Meer oor
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Gestig
1991
Webwerf
Werknemers
285